» Articles » PMID: 18057233

An Integrative Bioinformatic Approach for Studying Escape Mutations in Human Immunodeficiency Virus Type 1 Gag in the Pumwani Sex Worker Cohort

Abstract

Human immunodeficiency virus type 1 (HIV-1) is able to evade the host cytotoxic T-lymphocyte (CTL) response through a variety of escape avenues. Epitopes that are presented to CTLs are first processed in the presenting cell in several steps, including proteasomal cleavage, transport to the endoplasmic reticulum, binding by the HLA molecule, and finally presentation to the T-cell receptor. An understanding of the potential of the virus to escape CTL responses can aid in designing an effective vaccine. To investigate such a potential, we analyzed HIV-1 gag from 468 HIV-1-positive Kenyan women by using several bioinformatic approaches that allowed the identification of positively selected amino acids in the HIV-1 gag region and study of the effects that these mutations could have on the various stages of antigen processing. Correlations between positively selected residues and mean CD4 counts also allowed study of the effect of mutation on HIV disease progression. A number of mutations that could create or destroy proteasomal cleavage sites or reduce binding affinity of the transport antigen processing protein, effectively hindering epitope presentation, were identified. Many mutations correlated with the presence of specific HLA alleles and with lower or higher CD4 counts. For instance, the mutation V190I in subtype A1-infected individuals is associated with HLA-B*5802 (P = 4.73 x 10(-4)), a rapid-progression allele according to other studies, and also to a decreased mean CD4 count (P = 0.019). Thus, V190I is a possible HLA escape mutant. This method classifies many positively selected mutations across the entire gag region according to their potential for immune escape and their effect on disease progression.

Citing Articles

Analysis of temporal changes in HIV-1 CRF01_AE gag genetic variability and CD8 T-cell epitope evolution.

Rafaqat W, Tariq U, Farooqui N, Zaidi M, Raees A, Zuberi M PLoS One. 2022; 17(5):e0267130.

PMID: 35536783 PMC: 9089901. DOI: 10.1371/journal.pone.0267130.


HIV-1 Subtypes and 5'LTR-Leader Sequence Variants Correlate with Seroconversion Status in Pumwani Sex Worker Cohort.

Sampathkumar R, Scott-Herridge J, Liang B, Kimani J, Plummer F, Luo M Viruses. 2018; 10(1).

PMID: 29295533 PMC: 5795417. DOI: 10.3390/v10010004.


HIV-1 Sequence Data Coverage in Central East Africa from 1959 to 2013.

Lamers S, Barbier A, Ratmann O, Fraser C, Rose R, Laeyendecker O AIDS Res Hum Retroviruses. 2016; 32(9):904-8.

PMID: 27353049 PMC: 5028903. DOI: 10.1089/AID.2016.0079.


A step-by-step overview of the dynamic process of epitope selection by major histocompatibility complex class II for presentation to helper T cells.

Sadegh-Nasseri S F1000Res. 2016; 5.

PMID: 27347387 PMC: 4902097. DOI: 10.12688/f1000research.7664.1.


Immune activation promotes evolutionary conservation of T-cell epitopes in HIV-1.

Sanjuan R, Nebot M, Peris J, Alcami J PLoS Biol. 2013; 11(4):e1001523.

PMID: 23565057 PMC: 3614509. DOI: 10.1371/journal.pbio.1001523.


References
1.
Sham P, Curtis D . Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet. 1995; 59(1):97-105. DOI: 10.1111/j.1469-1809.1995.tb01608.x. View

2.
Musey L, Hu Y, Eckert L, Christensen M, Karchmer T, McElrath M . HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women. J Exp Med. 1997; 185(2):293-303. PMC: 2196121. DOI: 10.1084/jem.185.2.293. View

3.
Novitsky V, Cao H, Rybak N, Gilbert P, McLane M, Gaolekwe S . Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C. J Virol. 2002; 76(20):10155-68. PMC: 136554. DOI: 10.1128/jvi.76.20.10155-10168.2002. View

4.
Mo X, Cascio P, Lemerise K, GOLDBERG A, Rock K . Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides. J Immunol. 1999; 163(11):5851-9. View

5.
Druillennec S, Caneparo A, de Rocquigny H, Roques B . Evidence of interactions between the nucleocapsid protein NCp7 and the reverse transcriptase of HIV-1. J Biol Chem. 1999; 274(16):11283-8. DOI: 10.1074/jbc.274.16.11283. View